New Delhi, March 20 Eris Lifesciences launched a generic version of Semaglutide under the brand name 'Sundae' in the country on Friday, capitalizing on the expiration of patents for molecules similar to Ozempic and Wegovy in India.The company stated that it is introducing the diabetes and...
New Delhi, March 17 Zydus Lifesciences announced on Tuesday that it has entered into a licensing and supply agreement with Lupin to expand access to the diabetes treatment drug Semaglutide Injection (15 mg/3 ml) with a patient-friendly, reusable pen device in India.The agreement aims to...